+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of the platelet activating factor antagonist bn 52021 on the hyperglycemia induced by alloxan



The effect of the platelet activating factor antagonist bn 52021 on the hyperglycemia induced by alloxan



Prostaglandins 34(2): 188




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029336709

Download citation: RISBibTeXText


Related references

Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation. British Journal of Dermatology 122(4): 539-544, 1990

Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins 35(5): 757-770, 1988

Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. Biochemical and Biophysical Research Communications 163(1): 118-123, 1989

Protective effect of the platelet activating factor paf antagonist bn 52021 against diet induced atherosclerosis in the rabbit. Biorheology 26(3): 637, 1989

The effect of platelet activating factor and bn 52021 a platelet activating antagonist on the biology of lymphocytes. FASEB Journal 2(5): ABSTRACT 5482, 1988

Protective effect of a specific platelet activating factor antagonist, Bn 52021, on bupivacaine-induced cardiovascular impairments in rats. Pharmacological Research 21(5): 577-585, 1989

The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals. International Journal of Pancreatology 8(1): 1-11, 1991

Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat. Advances in Experimental Medicine and Biology 264: 419-422, 1990

Protective effect of a specific platelet-activating factor antagonist, BN 52021, on bupivacaine-induced cardiovascular impairments in rats. Pharmacological Research 21(5): 577-585, 1989

Potentiation of the effect of cyclosporine a csa by bn 52021 a platelet activating factor paf antagonist on forced swimming induced behavioral despair in mice. Prostaglandins 34(2): 199, 1987

Sulfhydryl compounds in pancreatic tissue of rats with cerulein induced acute pancreatitis effect of platelet activating factor antagonist bn 52021. Digestion 46(3): 133-134, 1990

Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion. Environmental Health Perspectives 85: 65-69, 1990

Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. Atherosclerosis 78(2-3): 151-158, 1989

Reversal of the endotoxin-induced bronchial hyperreactivity to histamine by the platelet activating factor antagonist BN 52021. Pneumonologia i Alergologia Polska 60(Suppl. 2): 105-107, 1992

Platelet activating factor paf induced cardiopulmonary dysfunctions and their reversal with a paf antagonist bn 52021 in guinea pigs. FASEB Journal 6(4): A1315, 1992